Pharmaceuticals & Biotech.
Pharmaceuticals & Biotech.
SECTOR | 08 Jun 2023
ICICI Securities Limited
In Q4FY23, companies under our coverage delivered 14%/26%/16% YoY increase in revenue/EBITDA/PAT, respectively. Growth was led by better traction across India and US which also supported 214bps improvement in gross margin.
More from Pharmaceuticals & Biotech.
Recommended